| Name | Title | Contact Details |
|---|---|---|
Scott Rohleder |
Chief Technology Officer | Profile |
Carta empowers hospitals to personalize the delivery of care to the individual needs of each patient. Our insight here is that personalizing care is not only good from an outcome/clinical perspective (where most people focus in the context of personalization) but is also the best way to optimize operations. Currently, hospitals have to over provision their resources because they are set up to serve the generic patient; planning ahead for exactly the resources needed– no more, no less– is the best way to gain efficiency. The approach we`re advocating and enabling is to: 1) Find past patients similar to the current one being treated 2) Quantify what exactly happened to them during their journey through the hospital (this is where our model comes in) 3) Use machine learning to project what the particular patient in question will need, and what the patient can expect their experience to be in the hospital We`re applying this approach now to two use cases– supplies projection and bed usage projection– and we have a bunch of other use cases we`re planning on addressing in the future.
Citizens Choice Healthplan is a Cerritos, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
IDS Limited is a Scottsdale, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Braxia Scientific is a medical research company with clinics that provide innovative ketamine treatments for persons with depression and related disorders. Through its medical solutions, Braxia aims to reduce the illness burden of brain-based disorders, such as major depressive disorder among others. Braxia is primarily focused on (i) owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and (ii) research activities related to discovering and commercializing novel drugs and delivery methods. Braxia seeks to develop ketamine and derivatives and other psychedelic products from its IP development platform. Through its wholly owned subsidiary, the Canadian Rapid Treatment Center of Excellence Inc., Braxia currently operates multidisciplinary community-based clinics offering rapid-acting treatments for depression located in Mississauga, Toronto, Kitchener-Waterloo, Ottawa, and Montreal.
Esoterix Clinical Trial Services is a Cranford, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.